High expression of EIF4G1 has been found in various tumors and is associated with poor prognosis, including breast, lung, hypopharyngeal, and nasopharyngeal cancers [53–55], which is consistent with our findings. Here, EIF4G1 is linked to nasopharyngeal carcinoma.